01/24/2025
3:23 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
3:06 PM | Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
7:37 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
6:49 PM | DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:24 PM | Summit Therapeutics (Issuer)
Xia Yu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:30 PM | Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:39 PM | Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:17 PM | Cesano Alessandra (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:57 PM | Booth Robert F. (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:05 PM | Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:11 PM | Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SMMT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Summit Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
10/30/2024
6:33 AM | Summit Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024
6:06 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
4:08 PM | Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:54 PM | Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
4:28 PM | Summit Therapeutics (Filer)
| Form S-3ASR | |
09/13/2024
6:29 PM | Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
5:25 PM | DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:54 PM | DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
| Form SC 13D/A | |
09/13/2024
4:40 PM | Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:26 PM | Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:29 PM | Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
5:49 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
6:23 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:14 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:37 AM | Summit Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/27/2024
4:20 PM | Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:16 PM | Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/27/2024
3:27 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
4:14 PM | Summit Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/17/2024
4:25 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
1:03 PM | Summit Therapeutics (Filer)
| Form DEFA14A | |
06/03/2024
5:18 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
5:05 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
3:48 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
7:35 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
7:03 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:48 AM | Summit Therapeutics (Filer)
| Form 424B5 | |
05/01/2024
7:45 AM | Summit Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/01/2024
7:18 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
7:11 AM | Summit Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Your trading day could end at 11 AM (Ad) What do you usually do between 9:35 AM and 11:00 AM?
Catch up on emails? Attend a meeting? Maybe grab a coffee?
For me, it's become the most important part of my trading day.
85 minutes. That's usually all it takes.
Set up at 9:35 AM… Check back at 11:00 AM.
And when things work out, there's an extra $100 to $150 in my account… on a $1000 starting stake.
Sounds too simple, doesn't it? Tap this link and see the complete breakdown. |
04/15/2024
8:21 AM | Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
8:19 AM | Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/11/2024
3:35 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
4:52 PM | Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
4:43 PM | Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:47 PM | Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
3:42 PM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
7:27 PM | Dhingra Ankur (Reporting)
Summit Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:28 PM | Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
7:07 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
7:36 AM | Summit Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
11:15 PM | Summit Therapeutics (Filer)
| Form EFFECT | |
Free SMMT Stock Alerts